About Ipsen
Ipsen is a company founded in 1929.. The company has 5,360 employees as of December 31, 2024. Ipsen has completed 7 acquisitions, including Albireo Pharma, Canbex Therapeutics and Clementia. Ipsen offers products and services including Oncology Medicines, Rare Disease Treatments, and Neuroscience Products. Ipsen operates in a competitive market with competitors including Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
- Employees 5360 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ipsen Sa
-
Annual Revenue
$3.53 B (USD)8.73as on Dec 31, 2024
-
Net Profit
$359.35 M (USD)-46.32as on Dec 31, 2024
-
EBITDA
$1.08 B (USD)9.6as on Dec 31, 2024
-
Latest Funding Round
$617.66 K (USD), Grant
Dec 18, 2023
-
Investors
Qualium Investissement
& 1 more
-
Employee Count
5360
as on Dec 31, 2024
-
Investments & Acquisitions
Albireo Pharma
& 6 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Ipsen
Ipsen is a publicly listed company on the EURONEXT with ticker symbol IPN in France, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Ipsen
Ipsen offers a comprehensive portfolio of products and services, including Oncology Medicines, Rare Disease Treatments, and Neuroscience Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treatments for cancers like neuroendocrine tumors
Drugs for rare conditions such as liver diseases
Medicines for debilitating neurological conditions
Unlock access to complete
Unlock access to complete
Leadership Team
165 people
Software Development Team
160 people
Product Management Team
44 people
Human Resources and Administration
41 people
Finance and Accounting
36 people
Senior Team
32 people
Sales and Marketing
30 people
Operations Team
29 people
Unlock access to complete
Funding Insights of Ipsen
- Total Funding Total Funding
- Total Rounds 4
- Last Round Grant — $617,663
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2023 | Amount | Grant - Ipsen | Valuation |
investors |
|
| Apr, 2021 | Amount | Grant - Ipsen | Valuation |
investors |
|
| Jun, 2015 | Amount | Post-IPO - Ipsen | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ipsen
Ipsen has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Qualium Investissement and Ministry of Economy, Finance and Industrial and Digital Sovereignty. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ipsen
Ipsen has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include Albireo Pharma, Canbex Therapeutics and Clementia. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
ImCheck Therapeutics is focused on immune system modulation innovation.
|
2015 | ||||
|
Information on liposome injections for pancreatic cancer is provided.
|
2013 | ||||
|
Small Molecule to treat rare bone diseases such as Fibrodysplasia Ossificans Progressiva (FOP).
|
2012 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Ipsen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ipsen Comparisons
Competitors of Ipsen
Ipsen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| domain | founded_year | HQ Location |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| domain | founded_year | HQ Location |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| domain | founded_year | HQ Location |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for the treatment of multiple disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ipsen
Frequently Asked Questions about Ipsen
When was Ipsen founded?
Ipsen was founded in 1929 and raised its 1st funding round 69 years after it was founded.
How many employees does Ipsen have?
As of Dec 31, 2024, the latest employee count at Ipsen is 5,360.
What is the annual revenue of Ipsen?
Annual revenue of Ipsen is $3.53B as on Dec 31, 2024.
What does Ipsen do?
Ipsen is a mid-sized biopharmaceutical company focused on innovation and specialty care to improve patient health outcomes. The company develops and commercializes transformative medicines in oncology, rare disease, and neuroscience. With a commitment to precision focus on RD, Ipsen builds a pipeline at every stage from discovery to late-stage clinical development.
Who are the top competitors of Ipsen?
Ipsen's top competitors include Merck, Roivant Sciences and AbbVie.
What products or services does Ipsen offer?
Ipsen offers Oncology Medicines, Rare Disease Treatments, and Neuroscience Products.
Is Ipsen publicly traded?
Yes, Ipsen is publicly traded on EURONEXT under the ticker symbol IPN.
How many acquisitions has Ipsen made?
Ipsen has made 7 acquisitions, including Albireo Pharma, Canbex Therapeutics, and Clementia.
Who are Ipsen's investors?
Ipsen has 2 investors. Key investors include Qualium Investissement, and Ministry of Economy, Finance and Industrial and Digital Sovereignty.
What is Ipsen's ticker symbol?
The ticker symbol of Ipsen is IPN on EURONEXT.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.